|
ZNF609 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81879999999946E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.181500E-04 |
| Normal-vs-Stage2 |
2.521000E-03 |
| Normal-vs-Stage3 |
4.10550000000676E-05 |
| Normal-vs-Stage4 |
6.208700E-04 |
| Stage1-vs-Stage2 |
5.968000E-01 |
| Stage1-vs-Stage3 |
2.255600E-01 |
| Stage1-vs-Stage4 |
4.076800E-01 |
| Stage2-vs-Stage3 |
7.340800E-01 |
| Stage2-vs-Stage4 |
8.962000E-01 |
| Stage3-vs-Stage4 |
8.326400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.66380000000377E-05 |
| Normal-vs-AfricanAmerican |
4.822600E-01 |
| Normal-vs-Asian |
7.628900E-04 |
| Caucasian-vs-AfricanAmerican |
4.868100E-02 |
| Caucasian-vs-Asian |
6.088000E-01 |
| AfricanAmerican-vs-Asian |
2.901700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.649800E-04 |
| Normal-vs-Female |
6.33110000000103E-05 |
| Male-vs-Female |
9.934200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.160800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.193260E-04 |
| Normal-vs-Age(61-80Yrs) |
5.57369999999446E-05 |
| Normal-vs-Age(81-100Yrs) |
1.397820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.581000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.960420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.523800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.940000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.696600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.396800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.260830E-01 |
| Classical-VS-Follicular |
2.733800E-02 |
| Classical-VS-Other |
4.858200E-01 |
| Classical-VS-Normal |
1.141900E-03 |
| Tall-VS-Follicular |
9.516600E-01 |
| Tall-VS-Other |
9.230800E-01 |
| Tall-VS-Normal |
3.794200E-04 |
| Follicular-VS-Other |
9.618600E-01 |
| Follicular-VS-Normal |
7.7686999999993E-05 |
| Other-VS-Normal |
7.461500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.01739999999839E-05 |
| Normal-vs-N1 |
7.637300E-04 |
| N0-vs-N1 |
8.039200E-01 |
|
|
